These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37772351)

  • 1. Complete revascularization based on angiography derived fractional flow reserve versus incomplete revascularization in patients with ST-segment elevation myocardial infarction.
    Liu J; Zhang K; Wang X; Liu Z; Chen M; Fan F; Jia J; Hong T; Li J; Huo Y; Gong Y; Zheng B
    Cardiol J; 2024; 31(2):226-234. PubMed ID: 37772351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
    Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
    JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-Year Outcomes With Fractional Flow Reserve-Guided or Angiography-Guided Multivessel Percutaneous Coronary Intervention for Myocardial Infarction.
    Puymirat E; Cayla G; Simon T; Steg PG; Montalescot G; Durand-Zaleski I; Ngaleu Siaha F; Gallet R; Khalife K; Morelle JF; Motreff P; Lemesle G; Dillinger JG; Lhermusier T; Silvain J; Roule V; Labèque JN; Rangé G; Ducrocq G; Cottin Y; Blanchard D; Charles Nelson A; Djadi-Prat J; Chatellier G; Danchin N;
    Circ Cardiovasc Interv; 2024 Jun; 17(6):e013913. PubMed ID: 38785084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractional flow reserve-guided complete revascularization versus culprit-only revascularization in acute ST-segment elevation myocardial infarction and multi-vessel disease patients: a meta-analysis and systematic review.
    Wang LJ; Han S; Zhang XH; Jin YZ
    BMC Cardiovasc Disord; 2019 Mar; 19(1):49. PubMed ID: 30823897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implication of QFR in patients with ST-segment elevation myocardial infarction after drug-eluting stent implantation.
    Tang J; Chu J; Hou H; Lai Y; Tu S; Chen F; Yao Y; Ye Z; Gao Y; Mao Y; Zhuang S; Liu X
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):755-766. PubMed ID: 33044717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vessel fractional flow reserve-based non-culprit lesion reclassification in patients with ST-segment elevation myocardial infarction: Impact on treatment strategy and clinical outcome (FAST STEMI I study).
    Groenland FTW; Huang J; Scoccia A; Neleman T; Ziedses Des Plantes AC; Nuis RJ; den Dekker WK; Wilschut JM; Diletti R; Kardys I; Van Mieghem NM; Daemen J
    Int J Cardiol; 2023 Feb; 373():33-38. PubMed ID: 36436683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
    Perera D; Crake T; Lee V
    Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple angio-based coronary flow assessment of culprit vessels in primary percutaneous coronary intervention is associated with long-term prognosis after ST-segment-elevation myocardial infarction.
    Chen G; Westra J; Yang X; Zhang Y; Luo D; Hu X; Li G; Zhou Y; Tu S; Dong H
    Int J Cardiol; 2024 Aug; 409():132199. PubMed ID: 38782068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction.
    Böhm F; Mogensen B; Engstrøm T; Stankovic G; Srdanovic I; Lønborg J; Zwackman S; Hamid M; Kellerth T; Lauermann J; Kajander OA; Andersson J; Linder R; Angerås O; Renlund H; Ērglis A; Menon M; Schultz C; Laine M; Held C; Rück A; Östlund O; James S;
    N Engl J Med; 2024 Apr; 390(16):1481-1492. PubMed ID: 38587995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of complete revascularization using either angiography-guided or fractional flow reserve-guided drug-eluting stent implantation in non-culprit vessels in ST elevation myocardial infarction patients: insights from a study based on a systematic review and meta-analysis.
    Hideo-Kajita A; Garcia-Garcia HM; Kuku KO; Beyene SS; Azizi V; Meirovich YF; Melaku GD; Dheendsa A; Brathwaite EJ; Desale S; Soud M; Dan K; Ozaki Y; Waksman R; Lipinski M
    Int J Cardiovasc Imaging; 2018 Sep; 34(9):1349-1364. PubMed ID: 29779179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial.
    Denormandie P; Simon T; Cayla G; Steg PG; Montalescot G; Durand-Zaleski I; le Bras A; le Breton H; Valy Y; Schiele F; Cuisset T; Vanzetto G; Levesque S; Goube P; Nallet O; Angoulvant D; Roubille F; Charles Nelson A; Chatellier G; Danchin N; Puymirat E
    Circ Cardiovasc Interv; 2021 Nov; 14(11):e011314. PubMed ID: 34420366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiographically Guided Complete Revascularization Versus Selective Stress Echocardiography-Guided Revascularization in Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease: The CROSS-AMI Randomized Clinical Trial.
    Calviño-Santos R; Estévez-Loureiro R; Peteiro-Vázquez J; Salgado-Fernández J; Rodríguez-Vilela A; Franco-Gutiérrez R; Bouzas-Mosquera A; Rodríguez-Fernández JÁ; Mesías-Prego A; González-Juanatey C; Aldama-López G; Piñón-Esteban P; Flores-Ríos X; Soler-Martín R; Seoane-Pillado T; Vázquez-González N; Muñiz J; Vázquez-Rodríguez JM
    Circ Cardiovasc Interv; 2019 Oct; 12(10):e007924. PubMed ID: 31554422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.
    Kobayashi Y; Lønborg J; Jong A; Nishi T; De Bruyne B; Høfsten DE; Kelbæk H; Layland J; Nam CW; Pijls NHJ; Tonino PAL; Warnøe J; Oldroyd KG; Berry C; Engstrøm T; Fearon WF;
    J Am Coll Cardiol; 2018 Sep; 72(12):1321-1329. PubMed ID: 30213322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.
    Kim MC; Ahn JH; Hyun DY; Lim Y; Lee SH; Oh S; Cho KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Cho JH; Lee SR; Kang DO; Hwang JY; Youn YJ; Jeong YH; Park Y; Kim DB; Choo EH; Kim CJ; Kim W; Rhew JY; Lee JH; Yoo SY; Ahn Y;
    Am Heart J; 2024 Jul; 273():35-43. PubMed ID: 38641031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of fractional flow reserve guided complete revascularization versus infarct related artery only revascularization in patients with ST-elevation myocardial infarction and multivessel coronary artery disease.
    Neupane S; Singh H; Edla S; Altujjar M; Yamsaki H; Lalonde T; Rosman HS; Eggebrecht H; Mehta RH
    Coron Artery Dis; 2019 Sep; 30(6):393-397. PubMed ID: 31094897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vessel fractional flow reserve in assessment of non-culprit lesions in ST elevation myocardial infarction.
    Chang CC; Chuang MJ; Lee YH; Tsai YL; Lu YW; Chou RH; Wu CH; Lu TM; Huang PH; Lin SJ
    Open Heart; 2021 Jul; 8(2):. PubMed ID: 34341096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate versus staged complete myocardial revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A post hoc analysis of the randomized FLOWER-MI trial.
    Tea V; Morelle JF; Gallet R; Cayla G; Lemesle G; Lhermusier T; Dillinger JG; Ducrocq G; Angouvant D; Cottin Y; Chamandi C; le Bras A; Steg PG; Montalescot G; Nelson AC; Simon T; Chatellier G; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2022 Oct; 115(10):496-504. PubMed ID: 36096979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of the Flow Evaluation to Guide Revascularization in Multivessel ST-Elevation Myocardial Infarction (FLOWER-MI) trial.
    Puymirat E; Simon T; de Bruyne B; Montalescot G; Steg G; Cayla G; Durand-Zaleski I; Blanchard D; Danchin N; Chatellier G;
    Am Heart J; 2020 Apr; 222():1-7. PubMed ID: 32000067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.